Last reviewed · How we verify
NCT06033365: BEATMeth
Beginning Early and Assertive Treatment for Methamphetamine Use Disorder
NA trial testing care navigation in Methamphetamine Use Disorder in 192 participants. Completed in 29 September 2025.
31 December 2024
Quick facts
| Lead sponsor | Denver Health and Hospital Authority |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 192 |
| Start date | 11 April 2023 |
| Primary completion | 31 December 2024 |
| Estimated completion | 29 September 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- care navigation
Conditions studied
- Methamphetamine Use Disorder — all drugs for Methamphetamine Use Disorder →
Sponsor
Denver Health and Hospital Authority
Who can join
18 and older, any sex, with Methamphetamine Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall goal of the study is to evaluate the effectiveness of a secondary prevention strategy implemented at a systems-level to prevent stimulant related overdoses.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Novel Care Navigation Intervention for Patients with Methamphetamine Use Disorder.
Simpson SA, Newton C, Al-Tayyib A, Duarte KG, et al · · 2026 · PMID 41379402 · DOI 10.1007/s10597-025-01570-w
Verify or expand the search:
- PubMed search for NCT06033365
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Methamphetamine Use Disorder
Currently open trials in the same condition.
- NCT07226596 — Non-Abstinence Outcomes in Methamphetamine Use Disorder · NA · recruiting
- NCT07450027 — LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis · recruiting
- NCT06989853 — Methamphetamine and Troriluzole · EARLY_PHASE1 · recruiting
- NCT07459244 — ECG Findings in Methamphetamine Use · recruiting
- NCT06712446 — A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder · NA · recruiting
Other Denver Health and Hospital Authority trials
Trials by the same sponsor.
- NCT07435662 — Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver · NA · recruiting
- NCT06496035 — Blood Flow Restriction Training in Patients With Lower Extremity Fractures · NA · recruiting
- NCT06274359 — Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities · NA · terminated
- NCT07223918 — Personalized Decision-Aid to Guide Tracheostomy and Prolonged Mechanical Ventilation Decision-Making · completed
- NCT05603481 — CGM in Patients With ED's · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06033365 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Denver Health and Hospital Authority
- Last refreshed: 13 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06033365.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing